Larimar Therapeutics Stock Market Value
| LRMR Stock | USD 3.15 0.06 1.87% |
| Symbol | Larimar |
Can Biotechnology industry sustain growth momentum? Does Larimar have expansion opportunities? Factors like these will boost the valuation of Larimar Therapeutics. Expected growth trajectory for Larimar significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Larimar Therapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Larimar Therapeutics's market price often diverges from its book value, the accounting figure shown on Larimar's balance sheet. Smart investors calculate Larimar Therapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Larimar Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Larimar Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Larimar Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Larimar Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Larimar Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Larimar Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Larimar Therapeutics.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Larimar Therapeutics on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Larimar Therapeutics or generate 0.0% return on investment in Larimar Therapeutics over 90 days. Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases u... More
Larimar Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Larimar Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Larimar Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 20.14 | |||
| Value At Risk | (7.16) | |||
| Potential Upside | 6.96 |
Larimar Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Larimar Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Larimar Therapeutics' standard deviation. In reality, there are many statistical measures that can use Larimar Therapeutics historical prices to predict the future Larimar Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.12) |
Larimar Therapeutics February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 3.28 | |||
| Coefficient Of Variation | (4,821) | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.59 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 20.14 | |||
| Value At Risk | (7.16) | |||
| Potential Upside | 6.96 | |||
| Skewness | 0.1544 | |||
| Kurtosis | 0.7821 |
Larimar Therapeutics Backtested Returns
Larimar Therapeutics has Sharpe Ratio of -0.0218, which conveys that the firm had a -0.0218 % return per unit of risk over the last 3 months. Larimar Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Larimar Therapeutics' Risk Adjusted Performance of (0.01), mean deviation of 3.28, and Standard Deviation of 4.31 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.86, which conveys possible diversification benefits within a given portfolio. Larimar Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Larimar Therapeutics is expected to follow. At this point, Larimar Therapeutics has a negative expected return of -0.0935%. Please make sure to verify Larimar Therapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Larimar Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.39 |
Below average predictability
Larimar Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Larimar Therapeutics time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Larimar Therapeutics price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Larimar Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Pair Trading with Larimar Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Larimar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Larimar Stock
| 0.59 | VALN | Valneva SE ADR | PairCorr |
| 0.43 | PYC | Physiomics Plc | PairCorr |
| 0.42 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.39 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.36 | 6C1 | CytomX Therapeutics | PairCorr |
The ability to find closely correlated positions to Larimar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Larimar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Larimar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Larimar Therapeutics to buy it.
The correlation of Larimar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Larimar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Larimar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Larimar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Larimar Stock Analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.